InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
DYN
Result 292 decisions over 120 months
Reset filters
Direction ?
Both292 Bought15 Sold277
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: DYN
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
DYN Dyne Therapeutics, Inc.
12 Jun 2023
Brumm Joshua T
See Remarks
Sold at will
187,748
$2.37M
42.6%
DYN Dyne Therapeutics, Inc.
12 Jun 2023
McNeill Jonathan
See Remarks
Sold on a plan
1,000
$13.00K
1.5%
DYN Dyne Therapeutics, Inc.
9 Jun 2023
Brumm Joshua T
See Remarks
Sold at will
76,582
$1.02M
22.1%
DYN Dyne Therapeutics, Inc.
8 Jun 2023
Brumm Joshua T
See Remarks
Sold at will 2×
61,000
$806.69K
18.4%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
Farwell Wildon
Chief Medical Officer
Sold, plan not stated
7,441
$99.19K
7.4%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
Brumm Joshua T
See Remarks
Sold, plan not stated
7,318
$97.55K
2.2%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
HIGH SUSANNA GATTI
Chief Operating Officer
Sold, plan not stated
1,559
$20.78K
1.4%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
Beskrovnaya Oxana
Chief Scientific Officer
Sold, plan not stated
1,416
$18.88K
1.6%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
Scalzo Richard William
See Remarks
Sold, plan not stated
1,311
$17.48K
2.3%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
McNeill Jonathan
See Remarks
Sold, plan not stated
1,209
$16.12K
1.8%
DYN Dyne Therapeutics, Inc.
13 Mar 2023
McNeill Jonathan
See Remarks
Sold, plan not stated
1,000
$13.00K
1.5%
DYN Dyne Therapeutics, Inc.
18 Jan 2023
McNeill Jonathan
See Remarks
Sold, plan not stated
10,000
$140.30K
12.9%
DYN Dyne Therapeutics, Inc.
9 Jan 2023
McNeill Jonathan
See Remarks
Sold, plan not stated
30,150
$348.84K
30.8%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Rhodes Jason P
Director indirect
Bought
934,581
$10.00M
opened
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Atlas Venture Opportunity Fund II, L.P.
10% owner
Bought
934,581
$10.00M
opened
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Brumm Joshua T
See Remarks
Sold, plan not stated
3,322
$36.11K
1.0%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
HIGH SUSANNA GATTI
Chief Operating Officer
Sold, plan not stated
751
$8.16K
0.7%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Beskrovnaya Oxana
Chief Scientific Officer
Sold, plan not stated
680
$7.39K
0.7%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Farwell Wildon
Chief Medical Officer
Sold, plan not stated
628
$6.83K
0.6%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
McNeill Jonathan
See Remarks
Sold, plan not stated
472
$5.13K
0.5%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
Scalzo Richard William
See Remarks
Sold, plan not stated
312
$3.39K
0.6%
DYN Dyne Therapeutics, Inc.
10 Oct 2022
Brumm Joshua T
See Remarks
Sold, plan not stated
195,800
$2.44M
48.9%
DYN Dyne Therapeutics, Inc.
7 Oct 2022
Brumm Joshua T
See Remarks
Sold, plan not stated
14,200
$189.85K
6.5%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
Brumm Joshua T
See Remarks
Sold, plan not stated
3,384
$29.54K
1.6%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
HIGH SUSANNA GATTI
Chief Operating Officer
Sold, plan not stated
765
$6.68K
1.0%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
Beskrovnaya Oxana
Chief Scientific Officer
Sold, plan not stated
693
$6.05K
1.3%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
Farwell Wildon
Chief Medical Officer
Sold, plan not stated
640
$5.59K
1.0%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
McNeill Jonathan
See Remarks
Sold, plan not stated
481
$4.20K
0.8%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
Scalzo Richard William
See Remarks
Sold, plan not stated
308
$2.69K
1.1%
DYN Dyne Therapeutics, Inc.
2 Mar 2022
Farwell Wildon
Chief Medical Officer
Sold, plan not stated
5,617
$48.08K
7.8%
DYN Dyne Therapeutics, Inc.
23 Sep 2021
HIGH SUSANNA GATTI
Chief Operating Officer
Sold, plan not stated
2,451
$42.21K
6.8%
DYN Dyne Therapeutics, Inc.
21 Sep 2021
Brumm Joshua T
See Remarks
Sold, plan not stated
4,584
$73.85K
4.4%
DYN Dyne Therapeutics, Inc.
21 Sep 2021
Beskrovnaya Oxana
Chief Scientific Officer
Sold, plan not stated
827
$13.32K
4.4%
DYN Dyne Therapeutics, Inc.
21 Sep 2021
McNeill Jonathan
See Remarks
Sold, plan not stated
729
$11.74K
2.0%
DYN Dyne Therapeutics, Inc.
21 Sep 2021
Scalzo Richard William
See Remarks
Sold, plan not stated
492
$7.93K
4.4%
DYN Dyne Therapeutics, Inc.
20 Sep 2021
Brumm Joshua T
See Remarks
Sold, plan not stated
3,425
$53.46K
3.2%
DYN Dyne Therapeutics, Inc.
20 Sep 2021
Beskrovnaya Oxana
Chief Scientific Officer
Sold, plan not stated
617
$9.63K
3.2%
DYN Dyne Therapeutics, Inc.
20 Sep 2021
McNeill Jonathan
See Remarks
Sold, plan not stated
545
$8.51K
1.5%
DYN Dyne Therapeutics, Inc.
20 Sep 2021
Scalzo Richard William
See Remarks
Sold, plan not stated
367
$5.73K
3.2%
DYN Dyne Therapeutics, Inc.
21 Sep 2020
VV Manager II, LLC
10% owner indirect
Bought 2×
815,000
$15.49M
39.5%
DYN Dyne Therapeutics, Inc.
21 Sep 2020
Logos Global Management LP
10% owner indirect
Bought
700,000
$13.30M
87.0%
DYN Dyne Therapeutics, Inc.
21 Sep 2020
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
660,000
$12.54M
30.8%
Showing 251–292 of 292. ← Newer Page 6 of 6